Education ▼

SPECIALTY TOPICS

CURRENTLY VIEWING
Precision Medicine in Oncology^®

Breast Cancer

Gastrointestinal Cancer

Precision Medicine in Oncology^Â®

Single Versus Multiagent Therapy: It's Time to Revisit the Choices

Maurie Markman, MD discusses the importance of objective evidence when using a combination approach as opposed to a single-agent treatment.
Read More >>

Capivasertib Effective in AKT-Mutated Cancers

Novel Oral Paclitaxel Formulation Aims to Overcome Drawbacks of IV Version

New Tools Needed to Manage Toxicities in Modern Era of Cancer Therapy

Lead IMPACT Investigator Discusses Precision Medicine Across Tumor Types

Personalized Medicine in a Time of Depersonalized Patient-Doctor Relationships

View More Stories >>

View Conference Coverage

2018 San Antonio Breast Cancer Symposium

2018 ASH Annual Meeting

2018 Ruesch Center Symposium

2018 Chemotherapy Foundation Symposium

2018 New York Lung Cancers Symposium

Dr. Markman on Precision Medicine in Ovarian Cancer

Implementing Quality Standards and Personalized Approaches into Oncology

Dr. Borgen on Precision Medicine in Breast Cancer

Dr. Shiller on Hereditary Predisposition to Cancer

OncLive houses thousands of videos that provide updates and information.
See more Videos

Progress in CRC Precision Medicine

Therapy Selection in BRCA-Mutated Ovarian Cancer

Other Promising Targets in TNBC

Defining Recurrence in Patients With Metastatic RCC

Role of Molecular Testing in CRC Management

OncLive houses thousands of videos that provide updates and information.
See more Videos

Precision Medicine for NSCLC and the Role of APPs

Gastric/GEJ Cancers: Non-Immunotherapeutic Advancements

Ovarian Cancer: Treating Through Multiple Progressions

The Value of MRD Testing in Lymphoid Malignancies

Soft Tissue Sarcoma: An Increasing Number of Options

Olaratumab's Role in Soft Tissue Sarcoma

OncLive houses thousands of videos that provide updates and information.
See more Videos

Featured Program

Treatment of Advanced Head & Neck Squamous Cell Carcinoma

Ezra Cohen, MD; Robert Ferris, MD, PhD, FACS; and Jared Weiss, MD, provide a comprehensive overview of diagnosis and treatment of advanced head and neck squamous cell carcinoma (HNSCC), including multidisciplinary care and emerging evidence surrounding novel therapies. Treatment approaches to HPV-positive and HPV-negative tumors are explored.